Results

Total Results: 2,173 records

Showing results for "medications".
Users also searched for: medication reconciliation

201. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
     November 01, 2007 - Demographic and clinical characteristics and receipt of other medications were identified from health … While other medications are also commonly used for heart failure-related symptom control (e.g., digoxin … In addition, detailed information on the actual dose being taken for the various medications was not … Different classes of medications such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin … HPHC) Medications within 30 days before admission, N (%) β-blockers Acebutolol 7 (0.1) 6

202. Kravitz_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
     January 01, 2012 - expectations for care after their visits. o Most, but not all, of the unmet expectations concerned medications … • Patients may seem  to want medications when they actually want information, reassurance, or commitment

203. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - Treatment Strategies Medications There has been rapid development and approval of vasodilator medications … .19 The three medications most recently approved by the U.S. … Also, more data have been published on the older medications for PAH. … We also wanted to address which medications are effective for treating PAH and how the newer medications … Scientific information packets were requested from the manufacturers of medications and devices and

204. Attention Deficit Hyperactivity Disorder: Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
     October 01, 2011 - Concerns about adverse events led to discontinuation of medications for 15 to 20 percent of children … More children in the Midwest and South receive diagnoses and ADHD medications relative to the western … More people in the United States receive medications than in Europe and the rest of the world.98,103 … An important strength of research in the past decade is evidence for effective and safe medications … The global market for ADHD medications. Health Aff (Millwood). 2007;26(2):450­7. 99.

205. Crosscutting-Horizon-Scan-High-Impact-1312 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - The company is working with various pharmaceutical manufacturers to select medications for sensor … At the postdischarge visit, the discharge worker reconciles medications, reviews medication use with … The company has termed oral medications embedded with the sensor “digital medicines.” … can integrate this technology into FDA- approved oral pills and capsules and into medications under … Patients would take oral medications embedded with the sensors as prescribed by a physician.

206. Asthma-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_executive.pdf
     May 01, 2011 - symptoms (≤ twice per week).4 Persistent asthma treatment includes the use of long-term control medications … (most commonly inhaled corticosteroids [ICS]) to reduce airway inflammation and quick-relief medications … While the benefits of asthma treatment generally outweigh the potential risks, these medications can … or reduced use of long- term control medications, when compared with usual care and/or other breathing … ● Reduced long-term control medications Figure A.

207. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - , and adverse effects of the osteoporosis medications. … • Age, history of fracture, and number of concurrent medications do not appear to have an important … When these medications are administered to individuals with no prior fractures, these are individuals … What are the adherence and persistence with medications for the treatment and prevention of osteoporosis … including, but not limited to, dosing frequency, side effects of medications, co-morbid conditions,

208. Association Between Outcomes and Dental Services in People With Substance Use Disorder: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
     May 01, 2025 - by the inability to control the use of substances such as legal or illegal drugs, alcohol, and/or medications … Food and Drug Administration (FDA) issued a formal warning regarding buprenorphine medications that … - Detailed recommendations for patients on SUD medications included oral rinse immediately after … Medications, Counseling, and Related Conditions. … https://www.samhsa.gov/medications- substance-use-disorders/medications- counseling-related-conditions

209. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
     May 19, 2010 - high-quality evidence overall to reach conclusions about the efficacy of any off-label indications of these medications … Sub-Question 2: How do atypical antipsychotic medications compare with other drugs, including first … Adverse events associated with on-label use of the atypical antipsychotic medications will be summarized … grouped together due to their difference from the group of conventional, or typical, antipsychotic medications … We will also summarize adverse events associated with on-label use of the atypical antipsychotic medications

210. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
     July 13, 2011 - In general, the efficacy of first- and second-generation antidepressant medications is similar (Mulrow … patients find intolerable, and the risk for harm when taken in overdose or in combination with certain medications … symptoms such as anxiety, insomnia, and neurovegetative symptoms, do mediations or combinations of medications … These medications with new formulations (such as an extended release formulation) are approved by the … The new sub-question would explore the comparative efficacy of immediate and extended release medications

211. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
     December 04, 2015 - There is no consensus on the terminology to describe antipsychotic medications (e.g., first and second … medications!or!nonpharmacologic!therapy?!! ! ! ! … will be included providing these medications are monitored (dose) during the study. … Treatment of young people with antipsychotic medications in the United States. … Medicaid prior authorization policies for pediatric use of antipsychotic medications.

212. Disposition of Comments for CER 208 Treatment for Bipolar Disorder in Adults A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
     August 07, 2018 - However, for the anticonvulsant mood stabilizing medications, valproate/divalproex and lamotrigine, … Valproate/divalproex is one of the most frequently prescribed medications for individuals with bipolar … If results for different medications were from different time points, this is problematic. … • Antipsychotic medications • Antidepressant medications • Other medications • Other somatic therapies … with the other antipsychotic medications rather than grouping the medications based solely on their

213. Diabetes Medications for Adults with Type 2 Diabetes: An Update Focused on Monotherapy and Add-on Therapy to Metformin | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetes-update-2015/research-protocol

214. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
     January 01, 2012 - Researchers have also explored some existing pharmacotherapies (e.g., antianxiety medications, antipsychotic … medications, nutritional medications [methylated form of vitamin B12], selective serotonin and norepinephrine

215. Noninvasive Treatments for Low Back Pain: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
     November 01, 2016 - psychological therapy Function 10 RCTs ↔ ��� Acupuncture No acupuncture Pain, function 1 SR ++ ��� Medications … Spinal manipulation Sham manipulation or inert treatment Pain 11 RCTs − to + ��� Exercise, usual care, medications … pain and how well they work �� The available evidence for the adverse effects associated with the medications

216. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
     March 22, 2016 - , education and intellectual engagement, social engagement, alcohol, smoking, and substance abuse, medications … programs, smoking cessation, cognitively stimulating activities, social engagement, anti-inflammatory medications … stimulation  and training Community-­level interventions (built environment) Depression  treatments (medications … and  nonpharmacologic interventions) Diabetes treatments (medications and  nonpharmacologic interventions … Physical activity  (aerobic, resistance  training, balance, dancing) Sleep  Disorder treatments (medications

217. Reducing Hospital Length of Stay Supplemental Info (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nom-length-stay-supplement.pdf
     June 27, 2019 - strategies may include: • Clinical care approaches to reducing LOS (e.g., switching from IV to oral medications

218. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Thus, an unmet need has existed for novel, effective medications to improve outcomes in this patient … patient’s benefits. 3 Clinical Pathway at Point of This Intervention Routine use of inhaled medications … Treatment includes smoking-cessation counseling and nicotine-addiction treatment, medications to address … Available: http://www.onlinepharmacycatalog.com/drugs- medications/antibiotics/azithromycin/zithromax … Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

219. Ch 5-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
     January 01, 2012 - For example, when comparing the adverse metabolic consequences of individual antipsychotic medications … Spectrum of Possible Comparisons Comparison interventions may include medications, procedures, medical … Nonadherence Nonadherence to prescribed medications is common and a recognized problem for the health … Adherence to Drugs and Device Failure or Removal Patients who are on medications could have various … degrees of adherence, from completely stopping, skipping doses, to taking medications as prescribed

220. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
     June 15, 2010 - switching to other SSRIs, 3) switching to other classes of antidepressants, 4) combining SSRIs with other medications … Some definitions suggest that the failures should be to medications of different classes, but this is … review showed that there was limited high quality evidence describing optimal strategies to switch medications … Antidepressants, 5) Other Non-SSRI Antidepressants, 6) Non- pharmacological therapies and 7) Augmenter medications … Antidepressants, 5) Other Non-SSRI Antidepressants, 6) Non- pharmacological therapies and 7) Augmenter medications